Drug profile · INN
fospropofol disodium
LUSEDRA
fospropofol disodium (LUSEDRA) is a unknown. Route of administration: intravenous. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — fospropofol disodium
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 3
- Data quality
- 0.84
Quick answer
fospropofol disodium (LUSEDRA) is a unknown. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN fospropofol disodium
Brand LUSEDRA
Mechanism Unknown
Route INTRAVENOUS
Formulation SOLUTION
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is fospropofol disodium?
fospropofol disodium (LUSEDRA) is a unknown. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for fospropofol disodium?
LUSEDRA is a marketed brand name for fospropofol disodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fospropofol disodium?
fospropofol disodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.